Rejuvenation Technologies
- Biotech or pharma, therapeutic R&D
Rejuvenation Technologies is entering clinical stage (2026) testing of telomere extension to enable stem cells to regenerate tissues, with strong preclinical data in hematologic, pulmonary, and hepatic models and patient cells. Awarded over $11M in grants.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}